Introduction ▼
Phosphodiesterases (PDEs) are enzymes that hydrolyze cyclic AMP (cAMP) and/or cyclic GMP (cGMP) throughout the body, including the brain. PDE inhibitors present a novel therapeutic approach with which to arrest cognitive decline [1, 2] or possibly reverse the decline with cognition enhancement [3, 4] . Evidence is accumulating that the second-messenger molecules cGMP and cAMP are important in memory processes in general and in long-term potentiation in particular [5, 6] . 11 subclasses of PDEs have been identified thus far, but only PDE4, 5 and recently PDE2 inhibitors have been demonstrated to be effective in memory enhancement [7] . Selective PDE4 inhibitors (PDE4-I) selectively inhibit the hydrolysis of cAMP. Ample evidence suggests a role for the cAMP/Protein Kinase A/cAMP Response Elementbinding Protein (cAMP/PKA/CREB) pathway in the cognition-enhancing abilities of PDE4-I [8] . In particular, the selective PDE4 inhibitor rolipram has been widely tested in cognition studies [7] . Zaprinast was used to inhibit PDE5, and when given immediately after training at a dose of 10 mg/kg (i. p.) it improved the long-term memory performance of rats in the object recognition task [14] . Previous studies also showed that zaprinast reversed the object memory deficits induced by the NOS inhibitor 7-nitroindazole in rats in the object recognition task [14] . However, zaprinast was unable to reverse memory deficits in aged rats in this task [15] . Animal studies indicate that PDE5 inhibitors have the potential to improve early consolidation processes of long-term memory, though this may be excluded for spatial information. This memory improvement might be mediated by elevations in central cGMP levels [12] [13] [14] . The aim of this study is to investigate the effect of the phosphodiesterase 4 inhibitor, rolipram, and the phosphodiesterase 5 inhibitor zaprinast on hippocampal dependent spatial memory in Morris water maze (MWM) and radial arm maze (RAM) tests in naive mice. Although there are some studies investigating the effects of rolipram on memory in the MWM and RAM tests [7, 9, 10] , these studies are restricted and controversial; there is no study investigating the effects of zaprinast on memory in the MWM and RAM tests. We aimed to investigate and compare the role of phosphodiesterase 4 and 5 on cognition in this study.
Materials and Methods

▼
Animals
A total of 65 male inbred BALB/c ByJ mice (MAM TUBİTAK, Gebze, Kocaeli, Turkey), aged 7 weeks upon arrival at the laboratory, were used in this study. The animals (4-5 per cage) were kept in the laboratory at 21 ± 1.5 ℃ with 60 % relative humidity under a 12 h light/dark cycle (light on at 8.00 p.m.) for 2 weeks before experimentation. Tap water and food pellets were available ad libitum. All procedures involving animals were in compliance with the European Community Council Directive of 24 November 1986, and ethical approval was granted by the Kocaeli University Ethics Committee (Number: AEK 9/4-2010, Kocaeli, Turkey). All animals were naive to the experimental apparatus, and different animals were used for each test.
Morris Water Maze Test (MWM)
The Morris water maze was a circular pool (90 cm diameter and 30 cm height) filled with water (22 ℃) to a depth of 14 cm and rendered opaque by the addition of small black balls. The pool was located in a dimly lit, soundproof test room with various visual cues, including a white-black colored poster on the wall, a halogen lamp, a camera and the experimenter. The maze was divided into 4 quadrants and 3 equally spaced points served as starting positions around the edge of the pool. The order of the release positions varied systematically throughout the experiment. A circular escape platform (6 cm diameter and 12 cm high) was located in one quadrant 1 cm above the water surface during the familiarization session and 1 cm below the water surface during the other sessions.
Video tracking was conducted with a video camera focused on the full diameter of the pool. Navigation parameters were analyzed by the Ethovision 3.1 video analysis system (Noldus, The Netherlands). The mice were trained in the Morris water maze 5 times daily (Familiarization sessions S 1 , S 2 , S 3 , S 4 ). One familiarization and 4 acquisition sessions were performed using the Morris water maze. During the familiarization session and acquisition phase of the experiment, each mouse was given
Radial Arm Maze test (RAM)
The experimental device was an elevated maze with 8 open arms (32-cm long and 5-cm wide) leading to an 8-cm square platform, which radiated from a central circular platform 44 cm in diameter with 1-cm high sides surrounding each arm. A small cup, 1 cm in diameter, was embedded in each distal platform and contained a hidden 10-mg noodle used as reinforcement. The maze was oriented in a small room; on the walls, 4 large black, white or black and white-striped patterns were hung, which provided particularly salient visual extramaze cues. For further details on the apparatus, see Beuzen et al. [16] . 24 h prior to training, the mice were deprived of food but not water; their weight loss reached 15-20 % of the initial body weight by the start of testing. Radial arm maze procedure was applied according to Belzung et al. [17] . The mice were first given 2 pre-training sessions at 24-h intervals. Groups of 4 mice were placed on the maze together for 20 min per session and could freely explore the 8 arms, which contained abundant food. Following pre-training, mice were given 5 training sessions, at 90-min intervals. After baiting the 8 arms with a 10-mg noodle, a mouse was placed on the central platform. The sessions were terminated when the animal had visited all 8 arms and eaten the rewards, after 16 arms were visited (regardless of which arms) or after a maximum of 15 min. The maze was quickly cleaned with ethanol to remove fecal deposits and urine after each mouse had completed testing. An error was recorded when the mouse entered an arm previously visited during the retention session. The total number of errors and the latency of retention session (time taken to complete the task) were scored. Because the effects of drugs on locomotor activity of the animals may cause false results, the speed of the animals was recorded using ethovision-XT (Noldus, Netherlands).
Drug administration
Zaprinast and rolipram were purchased from Sigma Chemical Company (Sigma, St. Louis, MO) and dissolved in saline supplemented with % 5 DMSO. All drugs were freshly prepared and administered in a volume of 0.1 ml per 10 g body weight. The control groups received the same volume of vehicle. Zaprinast (3 and 10 mg/kg), rolipram (0.05 and 0.1 mg/kg) or vehicle was administered intraperitoneally (i. p.) 60 and 30 min, respectively, for 6 days before the acquisition trials and probe trial of MWM test and before the retention trial of RAM test. The number of animals per group ranged from 6 to 7. The effective dose of each drug and the administration time was selected according to previous behavioral and neurochemical studies [18] . The mean distance to the platform significantly decreased in the rolipram (0.05 and 0.1 mg/kg) groups, while zaprinast had a partial effect on the mean distance to the platform in the probe trial. There was no significant difference between the speeds of the animals in the probe trial of the MWM test. In the RAM test, the number of errors in the retention trial significantly decreased in the zaprinast (3 and 10 mg/kg) groups, while rolipram had a partial effect that was not significant. The latency of the animals significantly decreased in the zaprinast (10 mg/kg) and rolipram (0.05 and 0.1 mg/kg) groups in the RAM test. Phosphodiesterase enzymes may be involved in the etiology of a number of CNS diseases, including Alzheimer's disease, schizophrenia, and affective disorders, and have recently been proposed as potential targets for therapeutic intervention [19, 20] . In addition, PDEs may be targeted for cognitive enhancement, and inhibitors of PDEs have proven to be useful experimental tools in exploring mechanisms of learning and memory [7, 13] . There is ample evidence that cGMP and cAMP are differentially involved in memory consolidation processes [13] . Several studies have observed memory-enhancing effects of PDE5-Is when injected before or directly after training [21, 22] . Initially, cGMP was thought to act mainly pre-synaptically in the early phase of long-term potentiation via the NO/sGC/cGMP pathway in the effects of PDE5-Is. Alternatively, the cGMP/PKG pathway has repeatedly been proposed as the underlying mechanism of action for early memory consolidation [23, 24] . At present, it is unclear which pathway underlies the memory-enhancing effects of selective PDE5 inhibition. Studies are underway to localize the PDE5 enzyme at the subcellular level. The data for PDE4 inhibitors are assumed to be related to elevated cAMP levels [25] . cAMP is involved in late-phase long-term potentiation via the cAMP/PKA/CREB pathway [26, 27] . Furthermore, it has been suggested that specifically late consolidation processes are affected by cAMP at 3 h after acquisition [5] . The prototypical PDE4 inhibitor most widely used in cognition studies is rolipram. It possesses good brain penetration and a half-life of 1-3 h [28] , and in vitro studies showed that cAMP levels are increased in hippocampal slices treated with rolipram [29] . Studies have shown that rolipram produces memoryenhancing effects in a number of models and has antidepressant-like activity in both preclinical [30] and clinical models [31] . In 1997, it was first described that PDE5 inhibition improves memory processes [14] . Zaprinast was used to inhibit PDE5, and when given immediately after training at a dose of 10 mg/kg (i. p.) improved the LTM performance of rats in the object recognition task [14] . However, zaprinast also inhibits PDE1, 9, 10 and 11. It has been observed that the systemic administration of cGMPselective phosphodiesterase inhibitors such as zaprinast and also other phosphodiesterase inhibitors decrease blood pressure, most likely by lowering the total peripheral resistance in conscious rats [32, 33] . Surprisingly, a slight increase in mean arterial blood pressure after administration of 10 mg/kg zaprinast was observed in a previous study [14] . Normally, a depressor response after systemic administration of zaprinast is observed but at doses above 10 mg/kg zaprinast [32, 33] . Closer examination of the available data reveal a slight pressor response after administration of low doses of zaprinast (10 mg/kg) [32, 33] . The mechanism by which zaprinast elevates mean arterial blood pressure is not clear, but it might be due to ancillary pharmacological effects of zaprinast itself rather than reflexive mechanisms opposing an initial vasodilatation [32, 33] . Considering these data, it is unlikely that the effects on blood pressure after zaprinast treatment contribute to the memory improvement of zaprinast. The MWM test is a spatial and long-term memory task in which animals must use complex behavioral strategies to swim away from the pool wall, locate the platform, climb onto the platform, and remain on the platform [34] . In our study, zaprinast and rolipram were injected subchronically for 6 consecutive days. A decrease in the escape latency during each acquisition session reflects the memory of the learned task. Because the location of the escape platform was not changed throughout the experiment, our results reflect hippocampal-dependent reference memory. Repeated administration of drugs before each acquisition session and before the probe test was performed to evaluate the effects of zaprinast and rolipram on learning and retrieval. This study revealed that rolipram (0.05 and 0.1 mg/kg) decreased the escape latency during the acquisition sessions, exerting a superior impact on learning compared to zaprinast. Both rolipram and zaprinast increased the time spent in the escape platform quadrant and decreased the mean distance traveled to the platform during the probe test. Therefore, both zaprinast and rolipram had an improving effect on spatial memory. The drug treatment did not affect the swimming speed of mice, supporting that both zaprinast and rolipram did not alter motor activity. Because the position of the platform did not change throughout It has been shown that the ability to make a series of correct choices in the RAM test depends on spatial information from extramaze cues [35] . In our protocol, the effect of drugs on spatial memory was evaluated because performance in the maze requires sufficient memory of the spatial environment. Each of the arms was baited with food, and reentry to a previously visited arm was accepted as an error; thus, spatial working memory was thought to be examined. Although there are some publications in which the effects of rolipram were assessed in the Morris water maze or in the radial arm maze [7, 9, 10, [36] [37] [38] , there wasn't sufficient study investigating the effect of zaprinast on learning and memory. In conclusion, the present study demonstrates that both PDE 5 inhibitor zaprinast and PDE 4 inhibitor rolipram enhanced spatial reference memory in the MWM test, while rolipram had superior effects on learning in the MWM test compared to zaprinast. Both zaprinast and rolipram enhanced spatial working memory in the RAM test, though the effects of zaprinast were more evident compared to rolipram. Our results confirm that the effects of zaprinast and rolipram on learning and memory seem to be test dependent, and future studies using different PDE inhibitors with different cognition methods can be performed to support our findings.
Effects of rolipram and zaprinast on learning and memory in the RAM test
